Tag Archives: RLD

LUPIN gets USFDA nod to market drug to treat THYROID

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered Lupin Ltd said of having got nod from US FDA (Food & Drugs Administration) to market drug to treat Thyroid and related disorders. In a press-release as submitted by the company to the Indian Bourses, titled –

Granules India’s foreign subsidiary gets USFDA nod to market insomnia treatment drug

HYDERABAD | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Bourses, Hyderabad headquartered pharma major Granules India Ltd said of its foreign subsidiary having got nod from US FDA (Food & Drugs Administration) to market insomnia (sleep disorder treatment) drug. The company statement submitted to the Indian Bourses read

Alembic Pharma gets USFDA nod to market drug to treat epilepsy & seizures

VADODARA (BARODA) | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a press release submitted to the Indian Stock Exchanges today, Vadodara (Baroda) headquartered Alembic Pharmaceuticals Ltd said of having received receives USFDA Approval for Clonazepam Orally Disintegrating Tablets USP, 0.125 mg, 0.25 mg, 0.5 mg, 1 mg and 2 mg. The press release submitted by

Alembic Pharma gets USFDA nod to market drug to treat influenza

VADODARA (BARODA) | MUMBAI | AHMEDABAD-GANDHINAGAR-RAJKOT – In a press release submitted to the Indian Bourses, Vadodara (Baroda) headquartered Alembic Pharmaceuticals Ltd said of having got approval from US Food & Drugs Administration (USFDA) to market drug to treat influenza. The press release submitted to the Indian Stock Exchanges read where the company said, Alembic

Alembic Pharma gets USFDA nod to market eye-care product, company is fighting litigation over same product in US Court

VADODARA (BARODA) | MUMBAI | RAJKOT – In a regulatory filing submitted to the Exchanges in India, Vadodara Headquartered and Amin family owned 100 years old pharma company – Alembic Pharmaceuticals Ltd said of having got nod from US FDA (Food & Drug Administration) to market eye-drops. Today, the Company today announced that they have

Alembic Pharma gets USFDA nod to market drug for Schizophrenia treatment

VADODARA (BARODA) | MUMBAI | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Alembic Pharmaceuticals Ltd said of having got approval from US FDA (Food & Drug Administration) to market drug to treat schizophrenia in adults. The company has received tentative approval from the USFDA for its Abbreviated New Drug Application (ANDA) for

Do NOT follow this link or you will be banned from the site!